ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics

HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, treated its first patient using Zeta Surgical's FDA-cleared Zeta TMS Navigation System at its Sarasota clinic. The technology uses AI and computer vision for real-time, markerless image guidance to enhance the precision of TMS therapy for depression and related disorders.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.